Dilators - Market Insights, Competitive Landscape, and Market Forecast - 2030

The market is expected to grow at a steady CAGR forecast till 2030 owing to the rising incidence of chronic conditions that require surgical intervention, such as pelvic organ prolapse, urinary tract disorders, and gastrointestinal issues, increase in technology advancement, and increase in product launches and approvals by key market players across the globe.

The global dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030. Chronic conditions such as pelvic organ prolapse, urinary tract disorders, and gastrointestinal issues often require surgical intervention to manage symptoms and improve patient quality of life. Dilators are essential tools in these procedures, used to expand or open body passages to facilitate access and treatment. Moreover, recent technological advancements in dilators have significantly boosted the market by enhancing their functionality, safety, and ease of use. Furthermore, key market players continuously investing in research and development to introduce innovative dilators, increased partnerships and collaborations, product launches and approvals ensures that market remains dynamic and innovative, during the forecast period from 2024 to 2030.

Dilators Market Dynamics:

According, to the data provided by the GLOBOCAN, in 2022 globally, the estimated new cases of esophagus cancer was 511,000 and the projection were indicated to increase 852,000 by 2045. Additionally as per the same source, the estimated new cases of bladder cancer in 2022 was 614,000 and the projection were indicated to increase 1.12 million by 2045. Thus, esophagus cancer can lead to esophageal strictures or narrowing of the esophagus, which can make swallowing difficult. Dilators are used in the treatment of esophageal strictures to gradually widen the narrowed sections, improving the patient’s ability to eat and drink. Additionally, bladder cancer treatment may involve surgical procedures that result in or exacerbate urethral strictures or bladder neck stenosis. Dilators are used to manage these complications by expanding narrowed areas of the urethra or bladder neck thereby boosting the overall market of dilators across the globe.

Additionally, the vaginal cancer often require gynecological surgeries. As per the latest data provided by International Agency of Cancer, in 2022, globally, the estimated new cases of vaginal cancer was 614,000 and the projections were indicated to increase 1.12 million by 2045. Treatment for vaginal cancer often involves surgery, radiation therapy, or both, which can lead to complications such as vaginal stenosis or narrowing. Dilators are essential for maintaining vaginal patency and elasticity post-treatment, helping to prevent or manage stenosis. They are used to support the healing process and maintain vaginal function, which is crucial for patients recovering from vaginal cancer treatments thereby escalating the market of dilators across the globe.

Furthermore, recent technological advancements in dilators have significantly boosted the market by enhancing their functionality, safety, and ease of use. Innovations such as ultra-thin, flexible materials allow for better navigation through anatomical structures, reducing trauma to surrounding tissues and minimizing patient discomfort. Additionally, the development of single-use dilators decreases the risk of cross-contamination and infection, aligning with the growing emphasis on patient safety in healthcare settings. Integration of advanced imaging techniques, such as real-time ultrasound or fluoroscopy, enables surgeons to visualize the target area more accurately, leading to improved procedural outcomes. For instance, in May 2021, Merit Medical Endotek announced the launch of the Elation5 Dilation Balloon, the first and only 5-stage balloon on the market. Elation5 was designed to incrementally dilate strictures in the gastrointestinal tract with the widest diameter range available on a single balloon catheter.

Thus, the factors mentioned above are likely to boost the market of dilators during the forecasted period.

However, the risk of infections and tissue damage associated with dilators and stringent regulatory concerns for product approval may hinder the future market of dilators.

Dilators Market Segment Analysis:

Dilators Market by Product Type (Gynecological Dilators, Urethral Dilators, Esophageal Dilators, Iris Dilators, and, Others), Type (Mechanical and Balloon), Application (Diagnostic and Treatment), End-User (Hospitals & Clinics, Healthcare Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the dilators market, urethral dilators are projected to hold a considerable market share in 2023. Urethral dilators are significantly boosting the overall market of dilators by addressing a critical need in the management of various urological conditions. These specialized tools are designed to gently and effectively widen the urethra, which is crucial for treating urethral strictures, stenosis, and other obstructive disorders of the urinary tract. Urethral dilators support a range of medical interventions, from diagnostic procedures to pre- and post-surgical treatments, by enabling improved access and reducing obstruction. Advances in dilator technology, such as the development of more precise and ergonomically designed devices, enhance their efficacy and ease of use, further driving market growth.

Additionally, the increasing product approval across the globe are further propelling the market of the segment. For instance, In July 2023, Urotronic, Inc. announced that it received FDA approval for its Optilume® BPH Catheter System. This minimally invasive therapy combines mechanical dilation with a double-lobe balloon and the localized delivery of paclitaxel to treat lower urinary tract symptoms (LUTS) from BPH.

Therefore, owing to the above-mentioned factors, the urethral dilators category is expected to generate considerable revenue thereby pushing the overall growth of the global dilators market during the forecast period.

North America is expected to dominate the overall dilators market:

Among all the regions, North America is expected to hold the largest share in the global dilators market in 2023. The dilators market in North America is witnessing growth due to several factors like increase in surgical procedure for various chronic diseases, increase adoption of minimally invasive surgeries, and presence of key market players involved in the market expansion of dilators market in North America, catering to the increasing demand for advanced treatments and technologies across the region.

According, to the recent data and stats provided by American Cancer Society (2024), in the United States, approximately 22,370 new cases of esophageal cancer were diagnosed, with 17,690 cases in men and 4,680 cases in women. Additionally, as per the same source there were 13,820 new cases of invasive cervical cancer in the United States.

Esophageal cancer often requires interventions that involve the use of dilators. For instance, after surgery or radiation therapy, patients may experience esophageal strictures or narrowing, which necessitates the use of esophageal dilators to maintain a patent esophagus and facilitate swallowing. Additionally, cervical cancer treatment, including surgery or radiation, can lead to vaginal stenosis or narrowing. Vaginal dilators are often used post-treatment to prevent or address this condition, helping to maintain vaginal elasticity and function thus, thereby boosting the overall market of dilators across the region.

Furthermore, recent merger, acquisitions, positive clinical trials, and product approvals among key market players in the region further propels the market across the region. For example, In June 2024, Materna Medical, Inc., a leader in women’s pelvic health solutions, announced the launch of a new clinical study called Prospective On Market Patient-reported Outcomes for Milli™ Vaginal Dilator (POMPOM). This important study aimed to collect data on how well the Milli Vaginal Dilator worked to relieve symptoms of veganism’s and painful intercourse.

Therefore, the factors mentioned above are expected to boost the growth of the dilators market in the North American region during the forecast period from 2024 to 2030.

Dilators Market Key Players:

Some of the key market players operating in the dilators market include Johnson and Johnson (Acclarent, Inc.), Hebson, CONMED Corporation, Scanlan International, Medtronic, Coloplast (Atos Medical AB), Teleflex Incorporated, Medpro Medical B.V., Boston Scientific Corporation, Soul Source Therapeutic Devices, Inc., Cook, Olympus, GPC Medical Ltd., Nidhi Meditech Systems, CooperSurgical, Inc., Hologic, Inc., MedGyn Products, Inc., Novo Surgical Inc., Medicem Group a.s., Panpac Medical Corp., and others.

Recent Developmental Activities in the Dilators Market:

• In August 2023, Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort® Coronary) announced that its Firefighter™ NC Pro PTCA dilation Balloon Catheter received FDA market authorization. This new high-pressure balloon catheter aimed to enhance myocardial perfusion and was designed for dilating narrowed sections of coronary arteries or bypass grafts, as well as for post-stent dilation. Key Takeaways From the Dilators Market Report Study:
• Market size analysis for current dilators size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the dilators market.
• Various opportunities available for the other competitors in the dilators market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current dilators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for dilators market growth in the coming future?

Target Audience who can be Benefited From This Dilators Market Report Study:

• Dilators product providers
• Research organizations and consulting companies
• Dilators -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in dilators
• Various end-users who want to know more about the dilators market and the latest technological developments in the dilators market.

Frequently Asked Questions for the Dilators Market:

1. What are dilators?

• A dilator is a surgical device that is used to induce an expansion of a passage or an opening inside the body.

2. What is the market for dilators?

• The global dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030.

3. What are the drivers for the dilators market?

• Chronic conditions such as pelvic organ prolapse, urinary tract disorders, and gastrointestinal issues often require surgical intervention to manage symptoms and improve patient quality of life. Dilators are essential tools in these procedures, used to expand or open body passages to facilitate access and treatment. Moreover, recent technological advancements in dilators have significantly boosted the market by enhancing their functionality, safety, and ease of use. Furthermore, key market players continuously investing in research and development to introduce innovative dilators, increased partnerships and collaborations, product launches and approvals ensures that market remains dynamic and innovative, during the forecast period from 2024 to 2030.

4. Who are the key players operating in the dilators market?

• Some of the key market players operating in the Dilators market include Johnson and Johnson (Acclarent, Inc.), Hebson, CONMED Corporation, Scanlan International, Medtronic, Coloplast (Atos Medical AB), Teleflex Incorporated, Medpro Medical B.V., Boston Scientific Corporation, Soul Source Therapeutic Devices, Inc., Cook, Olympus, GPC Medical Ltd., Nidhi Meditech Systems, CooperSurgical, Inc., Hologic, Inc., MedGyn Products, Inc., Novo Surgical Inc., Medicem Group a.s., Panpac Medical Corp., and others.

5. Which region has the highest share in the dilators market?

• Among all the regions, North America is expected to hold the largest share in the global dilators market in 2023. The dilators market in North America is witnessing growth due to several factors like increase in surgical procedure for various chronic diseases, increase adoption of minimally invasive surgeries, and presence of key market players involved in the market expansion of dilators market in North America, catering to the increasing demand for advanced treatments and technologies across the region.

This product will be delivered within 2 business days.